1:19-cv-00132 - Genentech Inc et al. v. Bactolac Pharmaceutical Inc et al.

Detail

Case Number

1:19-cv-00132

Current Status

closed

Cause of Action

Infringement

Related Case(s)

1:19-cv-00078

1:19-cv-00103

1:19-cv-00104

1:19-cv-00105

1:19-cv-00109

1:19-cv-00110

1:19-cv-00111

1:19-cv-00120

1:19-cv-00123

1:19-cv-00131

1:19-cv-00136

1:19-cv-00141

1:19-cv-00142

1:19-cv-00154

1:19-cv-00164

1:19-cv-00177

1:19-cv-00178

1:19-cv-00190

1:19-cv-00195

1:19-cv-00202

1:19-cv-00203

1:19-cv-00205

1:19-cv-00219

1:19-cv-00223

1:19-cv-00324

Court

Delaware District Court

Plaintiff(s)

Genentech Inc

Intermune Inc

Operating Company

Defendant(s)

Bactolac Pharmaceutical Inc

ScieGen Pharmaceuticals Inc

Judge

Richard G. Andrews

Filing Date

2019-01-23

Termination Date

2019-08-20

Not a member? Sign up for free!
Dockets
Text
CIVIL DOCKET
UPDATED CIVIL DOCKET
Summons Issued with Magistrate Consent Notice attached as to Bactolac Pharmaceutical Inc. on 1/24/2019; ScieGen Pharmaceuticals Inc. on 1/24/2019. Requesting party or attorney should pick up issued summons at the Help Desk, Room 4209, or call 302-573-6170 and ask the Clerk to mail the summons to them. (ceg) (Entered: 01/24/2019)
COMPLAINT FOR PATENT INFRINGEMENT filed against Bactolac Pharmaceutical Inc., ScieGen Pharmaceuticals Inc. - Magistrate Consent Notice to Pltf. (Filing fee $ 400, receipt number 0311-2551039.) - filed by InterMune, Inc., Genentech, Inc. (Attachments: # 1 Exhibits 1-5, # 2 Civil Cover Sheet)(ceg) (Entered: 01/24/2019)
Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 8,383,150 B2; 8,420,674 B2; 7,767,225 B2; 7,988,994 B2; 8,753,679 B2. (Attachments: # 1 Order)(nms) (Entered: 08/21/2019)
Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (ceg) (Entered: 01/24/2019)
Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 12/11/2018. Date of Expiration of Patent: see attached.Thirty Month Stay Deadline: 4/15/2022. (ceg) (Entered: 01/24/2019)
Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 8,383,150 B2; 8,420,674 B2; 7,767,225 B2; 7,988,994 B2; 8,753,679 B2. (ceg) (Entered: 01/24/2019)
Disclosure Statement pursuant to Rule 7.1: identifying Other Affiliate Roche Holdings, Inc. for Genentech, Inc.; Other Affiliate Genentech, Inc. for InterMune, Inc. filed by Genentech, Inc., InterMune, Inc. (ceg) (Entered: 01/24/2019)
SUMMONS Returned Executed by InterMune, Inc., Genentech, Inc.. Bactolac Pharmaceutical Inc. served on 1/24/2019, answer due 2/14/2019. (Blumenfeld, Jack) (Entered: 01/24/2019)
DECLARATION of Mailing, by Genentech, Inc., InterMune, Inc.. (Blumenfeld, Jack) Modified on 1/30/2019 (nms). (Entered: 01/25/2019)
NOTICE of Appearance by R. Touhey Myer on behalf of Bactolac Pharmaceutical Inc., ScieGen Pharmaceuticals Inc. (Myer, R.) (Entered: 02/07/2019)
Disclosure Statement pursuant to Rule 7.1: identifying Other Affiliate Bactolac Pharmaceutical Inc. for ScieGen Pharmaceuticals Inc. filed by ScieGen Pharmaceuticals Inc.. (Myer, R.) (Entered: 02/07/2019)
Disclosure Statement pursuant to Rule 7.1: No Parents or Affiliates Listed filed by Bactolac Pharmaceutical Inc.. (Myer, R.) (Entered: 02/07/2019)
STIPULATION TO EXTEND TIME for Defendants to answer the Complaint to March 15, 2019 - filed by Bactolac Pharmaceutical Inc., ScieGen Pharmaceuticals Inc.. (Myer, R.) (Entered: 02/07/2019)
MOTION for Pro Hac Vice Appearance of Attorney Robert Silver and Salvatore Guerriero of Caesar Rivise, PC - filed by Bactolac Pharmaceutical Inc., ScieGen Pharmaceuticals Inc.. (Myer, R.) (Entered: 02/08/2019)
MOTION for Pro Hac Vice Appearance of Attorney Mark E. Waddell, Warren K. MacRae and Ryan Hagglund of LOEB & LOEB LLP - filed by Genentech, Inc., InterMune, Inc.. (Jacobs, Karen) (Entered: 02/11/2019)
STIPULATION of Dismissal without Prejudice, by Genentech, Inc., InterMune, Inc.. (Jacobs, Karen) Modified on 3/7/2019 (nms). (Entered: 03/06/2019)
ANSWER to 1 Complaint, Affirmative Defenses, and COUNTERCLAIMS against All Plaintiffs, by ScieGen Pharmaceuticals Inc..(Myer, R.) Modified on 3/13/2019 (nms). (Entered: 03/12/2019)
ANSWER to 15 Answer to Complaint, and Counterclaims, by Genentech, Inc., InterMune, Inc..(Jacobs, Karen) Modified on 4/2/2019 (nms). (Entered: 04/02/2019)
NOTICE OF SUBSTITUTION OF COUNSEL re ScieGen Pharmaceuticals Inc.: Entry of appearance of attorney Patricia Smink Rogowski. Attorney R. Touhey Myer and Salvatore Guerriero terminated. (Rogowski, Patricia) (Entered: 07/23/2019)
PROPOSED Consent Order of Dismissal, by ScieGen Pharmaceuticals Inc.. (Rogowski, Patricia) Modified on 8/20/2019 (nms). (Entered: 08/15/2019)
SO ORDERED Granting 19 Proposed Consent Order of Dismissal (***Civil Case Terminated). Signed by Judge Richard G. Andrews on 8/20/2019. (nms) (Entered: 08/20/2019)
Timeline
filed_date
closed_date
2019
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
2020
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
2021
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
Patents In Case

Not a member? Sign up for free!